- Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
-
Shi T, Xiang L, Zhu J, Liu J, Zhang P, Wang H, Feng Y, Zhu T, Zhang Y, Yu A, Jiang W, Wang X, Zhu Y, Wu S, Teng Y, Zhang J, Jiang R, Zhang W, Jia H, Zang R
- KMID: 2537900
- J Gynecol Oncol.
- 2022 Jul;33(4):e63.
- doi: 10.3802/jgo.2022.33.e63
-
- CITED
-
- Close
- SHARE
-
- Close
- Detection of Spinal Muscular Atrophy Using a Duplexed Real-Time PCR Approach With Locked Nucleic Acid-Modified Primers
-
Pan J, Zhang C, Teng Y, Zeng S, Chen S, Liang D, Li Z, Wu L
- KMID: 2512739
- Ann Lab Med.
- 2021 Jan;41(1):101-107.
- doi: 10.3343/alm.2021.41.1.101
Background: Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder mainly caused by homozygous deletions that include exon 7 of the survival motor neuron 1 (SMN1) gene. A nearby... -
- CITED
-
- Close
- SHARE
-
- Close
- Preeclampsia serum-induced collagen I expression and intracellular calcium levels in arterial smooth muscle cells are mediated by the PLC-gamma1 pathway
-
Jiang R, Teng Y, Huang Y, Gu J, Ma L, Li M, Zhou Y
- KMID: 2155380
- Exp Mol Med.
- 2014 Sep;46(9):e115.
- doi: 10.1038/emm.2014.59
In women with preeclampsia (PE), endothelial cell (EC) dysfunction can lead to altered secretion of paracrine factors that induce peripheral vasoconstriction and proteinuria. This study examined the hypothesis that PE... -
- CITED
-
- Close
- SHARE
-
- Close
- A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
-
Shi T, Yin S, Zhu J, Zhang P, Liu J, Xiang L, Zhu Y, Wu S, Chen X, Wang X, Teng Y, Zhu T, Yu A, Zhang Y, Feng Y, Huang H, Bao W, Li Y, Jiang W, Zhang P, Li J, Ai Z, Zhang W, Jia H, Zhang Y, Jiang R, Zhang J, Gao W, Luan Y, Zang R
- KMID: 2500489
- J Gynecol Oncol.
- 2020 Apr;31(3):e61.
- doi: 10.3802/jgo.2020.31.e61
Background: In China, secondary cytoreductive surgery (SCR) has been widely used in ovarian cancer (OC) over the past two decades. Although Gynecologic Oncology Group-0213 trial did not show its overall... -
- CITED
-
- Close
- SHARE
-
- Close
